Showing results (371-380 of 421) with videos related to

Sort By:
Pageof 43
Annals of Hematology|May 23, 2026
Value of functional iron parameters in diagnostic re-assessment of MPN: refinement of iron-deficiency markers by zinc protoporphyrin (ZPP)Kirsi Manz, Myriam Kobrosly, Carl C Crodel, et al.
Cancer Research|January 17, 2009
Quantitative DNA methylation analysis of FOXP3 as a new method for counting regulatory T cells in peripheral blood and solid tissueGeorg Wieczorek, Anne Asemissen, Fabian Model, et al.
Haematologica|August 29, 2015
Outcome of advanced chronic lymphocytic leukemia following different first-line and relapse therapies: a meta-analysis of five prospective trials by the German CLL Study Group (GCLLSG)Paula Cramer, Susanne Isfort, Jasmin Bahlo, et al.
Journal of Telemedicine and Telecare|April 23, 2019
Experience with telepathology in combination with diagnostic assistance systems in countries with restricted resourcesPeter Fritz, Andreas Kleinhans, Monika Hubler, et al.
The Lancet. Oncology|December 15, 2015
Bendamustine plus rituximab versus fludarabine plus rituximab for patients with relapsed indolent and mantle-cell lymphomas: a multicentre, randomised, open-label, non-inferiority phase 3 trialMathias Rummel, Ulrich Kaiser, Christina Balser, et al.
International Journal of Cancer|August 19, 2015
Influence of mRNA expression of epiregulin and amphiregulin on outcome of patients with metastatic colorectal cancer treated with 5-FU/LV plus irinotecan or irinotecan plus oxaliplatin as first-line treatment (FIRE 1-trial)A Stahler, V Heinemann, C Giessen-Jung, et al.
Biorxiv : the Preprint Server for Biology|May 4, 2026
It's Not Rewarding for Mitochondria: Dopamine-Induced Mitochondrial Dysfunction Activates cGAS-STING to Drive IL-6 Secretion in MacrophagesMarzieh Daniali, Breana Channer, Erin O Curley, et al.
British Journal of Cancer|July 14, 2011
Correlation of capecitabine-induced skin toxicity with treatment efficacy in patients with metastatic colorectal cancer: results from the German AIO KRK-0104 trialS Stintzing, L Fischer von Weikersthal, U Vehling-Kaiser, et al.
Molecular Oncology|December 4, 2024
Evaluation of circulating tumor DNA as a prognostic and predictive biomarker in BRAF V600E mutated colorectal cancer-results from the FIRE-4.5 studySusanne Klein-Scory, Alexander Baraniskin, Wolff Schmiegel, et al.
European Journal of Cancer (Oxford, England : 1990)|October 26, 2010
Phase III trial of irinotecan plus infusional 5-fluorouracil/folinic acid versus irinotecan plus oxaliplatin as first-line treatment of advanced colorectal cancerLudwig Fischer von Weikersthal, Andreas Schalhorn, Martina Stauch, et al.
Pageof 43